Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cingulate Inc. Regulatory Filings 2021

Oct 14, 2021

34936_rns_2021-10-14_649786d2-4a56-42d4-b5aa-2d33a9f7b4c6.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm

October 14, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:
Registration Statement on Form S-1
File No. 333-259408

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on October 12, 2021, in which we, as representative of the several underwriters of Cingulate Inc.’s proposed initial public offering of common stock, joined Cingulate Inc.’s request for acceleration of the effective date of the above-referenced Registration Statement for Thursday, October 14, 2021, at 4:30 p.m. Eastern Time. Cingulate Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,

OPPENHEIMER & CO. INC.

As representative of the

several Underwriters

| OPPENHEIMER
& CO. INC. | |
| --- | --- |
| By: | /s/
Matthew Dormer |
| Name: | Matthew
Dormer |
| Title: | Managing
Director |

Field: Page; Sequence: 1; Options: Last

Field: /Page